AKT1 and cancer: In this study, it was found through experiments that the LNM of LSCC cells is linked to the overexpression of PI3K axis-related proteins in cancer tissues, and inhibiting the PI3K/Akt/mTOR axis activity may help reduce the risk of LNM in LSCC patients.